Novamind stock reddit update#

Novamind stock reddit update#

The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable laws. If you invested 10,000 in its first-ever public offering. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. Despite having an IPO just three months ago, Compass Pathways ( CMPS 4.41) is already up a staggering 224 from its IPO price of 17. The reader is cautioned not to place undue reliance on any forward-looking information. Important factors that could cause actual results to differ materially from the Company’s expectations including the risks detailed from time to time in the Company’s public disclosure. Stock accelerators Novamind’ s 52 week stock price high is 2.34 CAD which valued company at 100M it was at a time of hype in cannabis/psychedelic market with Democrats winning election and hope of new legislation since then it slid yet market signs suggest a combination of factors among many are in play as potential accelerators in. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties.

This news release contains forward-looking statements. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit novamind.ca. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of integrative mental health clinics and operates a full-service contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites. 5-MeO-DMT G2 Buys Peyote-Focused Psychedelics Company Lophos Pharma Novamind Stock Dives On 3.95M Private Placement With Institutional Investor UKs. We are pleased to contribute our clinical expertise and renowned therapy protocols to help achieve this vision.” Yaron Conforti, CEO and Director, Novamind, commented: “Bienstar is quickly developing Latin America’s first network of mental health clinics specialized in psychedelic medicine. stocks is progressing, Numinus completes its acquisition of Novamind. Upon signing a definitive agreement, Bienstar will have access to a broad patient base in Brazil-the largest market in Latin America with 215 million people. I got into NUMI at 0.31, so I shouldnt cry - only at all my other stock which are. Numinus To Acquire Novamind For 20.74M In Stock - Benzinga. manager at Horizons ETFs, about the Reddit rebellion on some stocks.

Rasmussen is a pioneer and one of the leading names in psychedelic medicine in Brazil where ketamine and ibogaine are legal for medical use in psychotherapies. r/Novamind: Novamind Investors Club (CSE: NM OTC: NVMDF FSE: HN2) Content here should. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ('Novamind'), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has closed its previously announced private placement to an institutional investor of its common shares. Bruno Rasmussen, Bienstar’s Chief Medical Officer, a medical doctor and MAPS-trained therapist with over 27 years of experience. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, ON / ACCESSWIRE / Janu/Novamind Inc. Yet based on past, quality of mgmt and timing in market seems very realistic.The Ibogaine Group is led by Dr. In a statement on February 22, Novamind also welcomed its inclusion in the ETF, a milestone achieved less than two months after the company went public on January 5, 2021. See Also Psychedelic Business News Roundup Stock Image. And the kicker to apply to list on Nasdaq. Today, much of the existing population in Gabon is Bantu, and Bwiti exists across several sects. Frankly, that could very well be the trigger for much wider support. In fact I could see Novamind using opportunity to execute a $20M private placement priced at $2 (clean with no warrants)to demonstrate institutional support for this valuation.

My guess is that with above the $2 price point is now realistic. YE report to show qe# of $2.4M and YE of $6M+ (eOct28)Įxpansion update for 2022 showing growth to at least 25 clinics in at least 3 states (e Oct 22)Īnnouncement of big name addition to Board of Directors (e Nov)Īnnouncement of 2 new clinical trials (by end of Oct) Novamind’ s 52 week stock price high is $2.34 CAD which valued company at $100M - it was at a time of hype in cannabis/psychedelic market with Democrats winning election and hope of new legislation- since then it slid yet market signs suggest a combination of factors among many are in play as potential accelerators in next 30 days:ĭenver report on psilocybin (Nov 9) expected to be national news